ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Amarin's Vascepa goes on TV to lay groundwork for impending CV outcomes data
August 01, 2018Amarin's heart drug Vascepa is casting its net with a first-ever TV ad campaign. Although the triglyceride-lowering drug has been on the market for five years, Amarin is anticipating cardiovascular outcomes data this fall—and if the trial comes up positiv -
Amarin (AMRN) Cut to “Sell” at Zacks Investment Research
December 26, 2017Zacks Investment Research lowered shares of Amarin (NASDAQ:AMRN) from a hold rating to a sell rating in a research report sent to investors on Wednesday.
Pharma Sources Insight January 2025
